Systematic Name: (3S)-10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
Synonyms of Pazufloxacin (CAS NO.127045-41-4): (-)-(3S)-10-(1-Aminocyclopropyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid ; 7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 10-(1-aminocyclopropyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-, (S)- ; H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 2,3-dihydro-10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-, (S)-
Product Categories: BacteriostaticAntibiotics;ChinolonesAlphabetic;PA - PENAnalytical Standards;Pharmacology Standards;Antibiotics;Chemical Structure;Chromatography;P;Principle;API's
CAS NO:127045-41-4
Molecular Formula: C16H15FN2O4
Molecular Weight: 318.3
Molecular Structure:
Index of Refraction: 1.692
Surface Tension: 76.4 dyne/cm
Density: 1.56 g/cm3
Flash Point: 275.2 °C
Enthalpy of Vaporization: 84.94 kJ/mol
Boiling Point: 531.5 °C at 760 mmHg
Vapour Pressure: 4E-12 mmHg at 25°C
Melting Point: 269-271°C
Pazufloxacin (CAS NO.127045-41-4) is used for the treatment of acute and chronic pneumonia, respiratory infections and other illnesses.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD | oral | > 2gm/kg (2000mg/kg) | Japanese Journal of Antibiotics. Vol. 48, Pg. 754, 1995. | |
dog | LDLo | intravenous | 400mg/kg (400mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: NAUSEA OR VOMITING | Japanese Journal of Antibiotics. Vol. 48, Pg. 754, 1995. |
mouse | LD | oral | > 5gm/kg (5000mg/kg) | Japanese Journal of Antibiotics. Vol. 48, Pg. 754, 1995. | |
mouse | LD | subcutaneous | > 5gm/kg (5000mg/kg) | SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | Japanese Journal of Antibiotics. Vol. 48, Pg. 754, 1995. |
mouse | LD50 | intravenous | 783mg/kg (783mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Japanese Journal of Antibiotics. Vol. 48, Pg. 754, 1995. |
rat | LD | oral | > 5gm/kg (5000mg/kg) | Chemotherapy Vol. 43(Suppl, | |
rat | LD | subcutaneous | > 5gm/kg (5000mg/kg) | SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | Japanese Journal of Antibiotics. Vol. 48, Pg. 754, 1995. |
rat | LD50 | intravenous | 341mg/kg (341mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Japanese Journal of Antibiotics. Vol. 48, Pg. 754, 1995. |
Hazard Codes: Xn,C,F
Risk Statements: 20/21/22-34-11
R11: Pazufloxacin (CAS NO.127045-41-4) is highly flammable.
R34: Causes burns.
R20/21/22: Harmful by inhalation, in contact with skin and if swallowed.
Safety Statements: 45-36/37/39-26-16
S16: Keep Pazufloxacin (CAS NO.127045-41-4) away from sources of ignition.
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
S36/37/39: Wear suitable protective clothing, gloves and eye/face protection.
RTECS: UU8815300
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View